Steven P Sedlis

Summary

Country: USA

Publications

  1. ncbi request reprint Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial)
    Steven P Sedlis
    Department of Medicine, Veterans Affairs New York Harbor Health Care System, New York University School of Medicine, New York, New York Electronic address
    Am J Cardiol 112:1703-8. 2013
  2. doi request reprint Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease
    Steven P Sedlis
    New York University School of Medicine, New York, NY, USA
    Am J Cardiol 104:1647-53. 2009
  3. pmc Periprocedural glycemic control in patients with diabetes mellitus undergoing coronary angiography with possible percutaneous coronary intervention
    Binita Shah
    Division of Cardiology, Department of Medicine, Veterans Affairs New York Harbor Health Care System and New York University School of Medicine, New York, New York Electronic address
    Am J Cardiol 113:1474-80. 2014
  4. doi request reprint Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial
    David J Maron
    Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA
    J Am Coll Cardiol 58:131-7. 2011
  5. pmc Mean platelet volume and long-term mortality in patients undergoing percutaneous coronary intervention
    Binita Shah
    Division of Cardiology, Department of Medicine, New York University School of Medicine and Veterans Affairs New York Harbor Health Care System, New York, New York, USA
    Am J Cardiol 111:185-9. 2013
  6. ncbi request reprint Very long-term clinical follow-up after fractional flow reserve-guided coronary revascularization
    Louis H Miller
    VA New York Harbor Health Care System New York Campus, New York, NY 10010, USA
    J Invasive Cardiol 24:309-15. 2012
  7. pmc Effectiveness of fluorography versus cineangiography at reducing radiation exposure during diagnostic coronary angiography
    Binita Shah
    Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York Electronic address
    Am J Cardiol 113:1093-8. 2014
  8. ncbi request reprint Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial)
    William E Boden
    VA Western New York Health Care System, Buffalo General Hospital, and the University at Buffalo, Buffalo, NY, USA
    Am J Cardiol 104:1-4. 2009
  9. ncbi request reprint Successful revascularization of a long chronic total occlusion with blunt microdissection complicated by coronary artery dissection
    Jeffrey D Lorin
    Division of Cardiology, Department of Veterans Affairs, New York Harbor Healthcare System, New York, NY, USA
    J Invasive Cardiol 16:673-6. 2004
  10. ncbi request reprint Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry
    Steven P Sedlis
    New York VA Medical Center and New York University School of Medicine, New York, New York 10010, USA
    Am J Cardiol 94:118-20. 2004

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial)
    Steven P Sedlis
    Department of Medicine, Veterans Affairs New York Harbor Health Care System, New York University School of Medicine, New York, New York Electronic address
    Am J Cardiol 112:1703-8. 2013
    ....
  2. doi request reprint Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease
    Steven P Sedlis
    New York University School of Medicine, New York, NY, USA
    Am J Cardiol 104:1647-53. 2009
    ..Although PCI did not reduce the risk of death or myocardial infarction when added to OMT for patients with CKD, it also was not associated with worse outcomes in this high-risk group...
  3. pmc Periprocedural glycemic control in patients with diabetes mellitus undergoing coronary angiography with possible percutaneous coronary intervention
    Binita Shah
    Division of Cardiology, Department of Medicine, Veterans Affairs New York Harbor Health Care System and New York University School of Medicine, New York, New York Electronic address
    Am J Cardiol 113:1474-80. 2014
    ....
  4. doi request reprint Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial
    David J Maron
    Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA
    J Am Coll Cardiol 58:131-7. 2011
    ..Our purpose was to clarify the clinical utility of identifying metabolic syndrome (MetS) in patients with coronary artery disease (CAD)...
  5. pmc Mean platelet volume and long-term mortality in patients undergoing percutaneous coronary intervention
    Binita Shah
    Division of Cardiology, Department of Medicine, New York University School of Medicine and Veterans Affairs New York Harbor Health Care System, New York, New York, USA
    Am J Cardiol 111:185-9. 2013
    ..However, increased mortality was found when the MPV increased over time after PCI. Monitoring the MPV after coronary revascularization might play a role in risk stratification...
  6. ncbi request reprint Very long-term clinical follow-up after fractional flow reserve-guided coronary revascularization
    Louis H Miller
    VA New York Harbor Health Care System New York Campus, New York, NY 10010, USA
    J Invasive Cardiol 24:309-15. 2012
    ..Real-world, long-term outcomes using an FFR-based revascularization strategy are unknown...
  7. pmc Effectiveness of fluorography versus cineangiography at reducing radiation exposure during diagnostic coronary angiography
    Binita Shah
    Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York Electronic address
    Am J Cardiol 113:1093-8. 2014
    ..48 to 7.80], p=0.059). In conclusion, the use of fluorography in a select group of patients during coronary angiography, with repeat injection under cineangiography only when needed, was efficacious at reducing patient radiation exposure...
  8. ncbi request reprint Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial)
    William E Boden
    VA Western New York Health Care System, Buffalo General Hospital, and the University at Buffalo, Buffalo, NY, USA
    Am J Cardiol 104:1-4. 2009
    ....
  9. ncbi request reprint Successful revascularization of a long chronic total occlusion with blunt microdissection complicated by coronary artery dissection
    Jeffrey D Lorin
    Division of Cardiology, Department of Veterans Affairs, New York Harbor Healthcare System, New York, NY, USA
    J Invasive Cardiol 16:673-6. 2004
    ..The case was complicated by a long coronary artery dissection, with inability to access the true lumen. With favorable healing at 7 weeks, the true lumen was accessible which led to procedural success...
  10. ncbi request reprint Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry
    Steven P Sedlis
    New York VA Medical Center and New York University School of Medicine, New York, New York 10010, USA
    Am J Cardiol 94:118-20. 2004
    ..This study reports the outcome of patients with LV ejection fraction <35% in the randomized clinical trial and the physician-directed and patient choice registries of the AWESOME study...
  11. ncbi request reprint A dual wire approach to severe ostial bifurcating renal artery stenosis
    Jeffrey D Lorin
    Division of Cardiology, VA New York Harbor Health System Manhattan Campus and New York University School of Medicine, New York, New York 10010, USA
    Catheter Cardiovasc Interv 67:956-60. 2006
    ..Using a single 7F sheath in each case, both renal artery branches were wired, and each branch was predilated and stented in a sequential fashion. Excellent angiographic results were obtained in both cases...
  12. ncbi request reprint Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry
    Steven P Sedlis
    Section of Cardiology, 12W, New York VA Medical Center, 423 East 23rd Street, New York, NY 10010, USA
    J Am Coll Cardiol 40:1555-66. 2002
    ....
  13. pmc Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout
    Daria B Crittenden
    Crystal Diseases Study Group, Division of Rheumatology, New York University School of Medicine, New York, New York 10003, USA
    J Rheumatol 39:1458-64. 2012
    ..We examined whether colchicine use was associated with a reduced risk of myocardial infarction (MI) in patients with gout...
  14. doi request reprint Effect of rosiglitazone on survival in patients with diabetes mellitus treated for coronary artery disease
    Alana Choy-Shan
    Department of Medicine, Veterans Affairs New York Harbor Health Care System, New York University School of Medicine, New York, New York 10010, USA
    Coron Artery Dis 23:354-8. 2012
    ..The purpose of this study was to assess the impact of rosiglitazone on survival in patients with diabetes mellitus (DM) and coronary artery disease (CAD)...
  15. doi request reprint Metabolic syndrome does not impact survival in patients treated for coronary artery disease
    Binita Shah
    VA New York Harbor Health Care System, New York, NY 10010, USA
    Coron Artery Dis 19:71-7. 2008
    ..We evaluated the effect of metabolic syndrome (a risk factor for the development of coronary artery disease) on survival in patients with established coronary artery disease...
  16. ncbi request reprint Relation of elevated periprocedural blood glucose to long-term survival after percutaneous coronary intervention
    Binita Shah
    Veterans Affairs New York Harbor Health Care System and New York University School of Medicine, New York, New York, USA
    Am J Cardiol 96:543-6. 2005
    ..This study reports the correlation of periprocedural blood glucose with long-term survival in 1,746 patients who underwent percutaneous coronary intervention from 1990 to 2003 in a Department of Veterans Affairs hospital...
  17. ncbi request reprint Rapid thrombectomy for treatment of macroembolization during percutaneous coronary intervention in the setting of acute myocardial infarction
    Jeffrey D Lorin
    Division of Cardiology, Department of Veterans Affairs, New York Harbor Healthcare System, New York Campus, New York, New York 10010, USA
    Catheter Cardiovasc Interv 59:219-22. 2003
    ..We report the use of the Export catheter as an urgent modality to aspirate thrombus that embolized down the left anterior descending artery during acute myocardial infarction...
  18. ncbi request reprint The ratio of ADP- to ATP-ectonucleotidase activity is reduced in patients with coronary artery disease
    Magdi M El-Omar
    Department of Medicine Cardiology, New York University Medical School, New York, NY, USA
    Thromb Res 116:199-206. 2005
    ..Based on data in animal models and in vitro, CD39 constitutes a new therapeutic modality for vascular disease with a novel and unique mode of action...